Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
The Deerborne Group announced that its senior leadership will attend the American Society of Clinical Oncology 2026 Annual Meeting in Chicago, where the firm will highlight its AI-enabled COMPASS 360 platform for diagnostics strategy and decision-making.
The Parkinson's Foundation has identified over 2,000 potential participants for Neuron23's NEULARK clinical trial using its new PD Trial Navigator program, which connects genetically eligible individuals with Parkinson's disease to relevant studies.
Octagos has introduced Ask Atlas, an AI tool that enables cardiac device clinics to query their clinical, operational, and billing data using natural language. The platform, built on Atlas AI, was previewed at the Heart Rhythm Society meeting in April 2026.
Tokyo and Palo Alto-based biotechnology company bitBiome has closed an oversubscribed seed extension round, bringing its total equity and non-dilutive funding to over 45 million USD. The company plans to expand its microbial enzyme discovery and engineering platforms and strengthen its global partnerships.
Prezent Vivo and Nested Knowledge have formed a strategic partnership to deliver AI powered competitive intelligence to life sciences teams, combining communication and evidence synthesis technologies to accelerate congress preparation and ongoing insights.
Tata Elxsi has introduced ViTel, a material intelligence platform co-developed with Viridium AI to help medical device manufacturers manage sourcing, compliance, and engineering decisions through AI-powered data integration.
b.well Connected Health and myTomorrows have announced a partnership to streamline clinical trial access by combining unified health data with AI-based trial matching technology.
NeuroXT and Beth Israel Deaconess Medical Center have entered a new phase of their collaboration to advance precision treatment for Alzheimer's disease using AI-based neuroimaging biomarkers.
HkeyBio has announced an expansion of its preclinical services for autoimmune and allergic diseases, adding new wet lab validation platforms and CRO service upgrades to meet growing demand from AI-driven drug discovery companies.
ABILITY Neurotech has received approval from Dutch regulators to begin a chronic implantation clinical trial for its fully implantable brain-computer interface in ALS patients. The study will be conducted at UMC Utrecht under the INTRECOM consortium.
Verified Market Research projects the global glucose tracking app market to grow from 5 billion dollars in 2025 to 12 billion dollars by 2033, driven by AI-based decision support and connected diabetes management tools.
Cornerstone Robotics has received European Union CE mark certification for its Sentire Surgical System, allowing market entry across the EU for minimally invasive procedures in multiple specialties.
Sanyou Biopharmaceuticals has launched Clicklinks, a new platform designed to connect global stakeholders in innovative drug discovery through a unified online ecosystem that integrates six core research and development modules.
Paragon Health Institute has published a research paper introducing a voluntary framework called Digital Similarity Analysis to improve the safety of medical devices that use artificial intelligence.
Collaborative Drug Discovery has announced a partnership with Eli Lilly and Company to integrate the Lilly TuneLab AI and machine learning drug discovery models into its CDD Vault platform, enabling biotech users to access Lilly’s predictive tools within their workflows.
Caris Life Sciences will present 32 studies at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, focusing on multi-omic biomarker research and real-world data analyses across multiple cancer types.
Leo Cancer Care has secured CE marking for its Marie upright radiotherapy system, allowing commercial use across Europe. The system enables patients to receive treatment while seated or standing, and installations have begun at CNAO in Italy.
Verana Health has expanded its real world data bladder cancer database to support research in genitourinary oncology. The update offers deeper insights into disease detection, treatment, and outcomes through curated data from electronic health records.
Helix has partnered with St. Luke’s University Health Network to introduce Helix Genomic Advantage, the first genomic benefit program focused on reducing total medical costs through precision medicine.
The Path, an AI therapy platform co-founded by Tony Robbins and Calm veterans, has raised $14.3 million in seed funding led by Prime Movers Lab to grow its proactive mental health care technology and research initiatives.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
